NYSE · Biotechnology

Ginkgo Bioworks Holdings, Inc. (DNA) Stock

$13.00 +14.64% NYSE: DNA Healthcare

Valuation

MetricValue
Price$13.00
Market Cap$849.22M
P/E Ratio-2.46
P/B Ratio1.82
P/S Ratio7.21
EPS (TTM)$-5.64
52-Week High$17.58
52-Week Low$5.37
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-60.21%
ROA-29.37%
ROCE-31.69%
Gross Margin-185.29%
Operating Margin-185.29%
Net Margin-259.96%
Debt/Equity0.96
Current Ratio4.92

Annual Financials (USD)

Metric20212022202320242025
Revenue$314.0M$478.0M$251.0M$227.0M$170.0M
Operating Profit$-1.8B$-2.2B$-864.0M$-560.0M$-315.0M
Net Profit$-1.8B$-2.1B$-893.0M$-547.0M$-313.0M
EPS$-55.53$-50.20$-18.40$-10.54$-5.64
Op Margin-582.6%-462.4%-343.8%-246.5%-185.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.1B$2.5B$1.7B$1.4B$1.1B
Total Liabilities$504.0M$803.0M$568.0M$661.0M$611.0M
Cash$1.6B$1.3B$944.0M$562.0M$167.0M
Borrowings$23.0M$443.0M$239.0M$468.0M$440.0M

Latest News

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery PR Newswire · May 26, 2026 Ginkgo Bioworks Holdings Inc (DNA): What’s the Future of Autonomous Lab? Insider Monkey · May 22, 2026 The Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Have Been Trimming Their Sales Forecasts Simply Wall St. · May 13, 2026 How The Ginkgo Bioworks (DNA) Story Is Shifting After The Biosecurity Divestiture And Target Cut Simply Wall St. · May 11, 2026 Ginkgo Bioworks Q1 Earnings Call Highlights MarketBeat · May 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-254.0M$-252.0M$-295.0M$-320.0M$-171.0M
Investing Cash Flow$-130.0M$-120.0M$-121.0M$-125.0M$-248.0M
Financing Cash Flow$1.5B$-3.0M$-1.0M$-1.0M$-1.0M
Net Cash Flow$1.2B$-223.0M$-380.0M$-384.0M$-393.0M
Free Cash Flow$-310.0M$-304.0M$-336.0M$-382.0M$-179.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.16
EV / EBITDA-5.39
FCF Yield-23.57%
Quick Ratio4.57
Interest Coverage0.00
Return 1Y-43.92%
Return 3Y-91.30%
Return 5Y-97.72%

Ownership

Insiders Held4.60%
Institutions Held68.68%
Institutions Float Held71.99%
Institutional HolderSharesReport Date
Blackrock Inc.3,642,3472026-03-31
Viking Global Investors, L.P.3,577,1282026-03-31
BAILLIE GIFFORD & CO2,391,6492026-03-31
Erste Asset Management GmbH1,947,7282026-03-31
Vanguard Capital Management LLC1,914,4282026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. is led by CEO Jason Kelly, employs 834 people, headquartered in US, publicly traded since 2021.

Ginkgo Bioworks Holdings, Inc. (DNA) stock trades at $13.00 with a market capitalization of $849.22M. The stock is valued at a price-to-earnings (P/E) ratio of -2.46, price-to-book of 1.82, price-to-sales of 7.21. Over the past 52 weeks the stock has ranged between $5.37 and $17.58, and currently trades 26.1% below its 52-week high.

On profitability, Ginkgo Bioworks Holdings, Inc. generates a return on equity (ROE) of -60.21%, return on capital employed of -31.69%, an operating margin of -185.29%, a net profit margin of -259.96%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides